On Monday, Quince Therapeutics Inc (NASDAQ: QNCX) opened higher 18.18% from the last session, before settling in for the closing price of $1.65. Price fluctuations for QNCX have ranged from $0.69 to $2.45 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 7.53%. Company’s average yearly earnings per share was noted 18.45% at the time writing. With a float of $41.11 million, this company’s outstanding shares have now reached $53.62 million.
Quince Therapeutics Inc (QNCX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Quince Therapeutics Inc is 23.46%, while institutional ownership is 13.76%.
Quince Therapeutics Inc (QNCX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.13 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.1) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.67% during the next five years compared to 7.53% growth over the previous five years of trading.
Quince Therapeutics Inc (NASDAQ: QNCX) Trading Performance Indicators
Check out the current performance indicators for Quince Therapeutics Inc (QNCX). In the past quarter, the stock posted a quick ratio of 5.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.10, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.74 in one year’s time.
Technical Analysis of Quince Therapeutics Inc (QNCX)
Compared to the last year’s volume of 0.23 million, its volume of 0.5 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 73.21%.
During the past 100 days, Quince Therapeutics Inc’s (QNCX) raw stochastic average was set at 92.48%, which indicates a significant decrease from 97.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0783 in the past 14 days, which was lower than the 0.1088 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6395, while its 200-day Moving Average is $1.4700. Nevertheless, the first resistance level for the watch stands at $2.0500 in the near term. At $2.1500, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.3400. If the price goes on to break the first support level at $1.7600, it is likely to go to the next support level at $1.5700. Should the price break the second support level, the third support level stands at $1.4700.
Quince Therapeutics Inc (NASDAQ: QNCX) Key Stats
There are currently 53,714K shares outstanding in the company with a market cap of 104.74 million. Presently, the company’s annual sales total 0 K according to its annual income of -56,830 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -16,050 K.
